chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms began at 5-10 minutes after receiving vaccine: Started with lips feeling swollen and numb, no difficulty breathing, approximately 20 minutes after vaccine back of throat became itchy, Oxygen levels normal and no difficulty breathing, a little over 30 minutes after vaccine both cheeks became numb, a few minutes later on walking to the bathroom an irritating cough and throat clearing started. at 45 minutes after vaccine tongue became itchy, still stable oxygen levels and decision was made to go across the lobby to the hospital ER for treatment. On arrival to the ER there was a rash on the chest and by 4:20pm almost 2 hours after vaccine coughing fit with difficulty catching breath occurred, 18 gauge IV was placed in Right arm and IV benadryl 25mg and IV solumedrol 125mg was given with Albuterol inhaler 6 puffs delivered in a spacer.  Symptoms began to resolve and almost gone within the hour of receipt of medications. Observation was continued for a total of 2 hours with Discharge by 7pm that evening. Discharge medication instructions were: Prednisone 50mg daily for 2 days starting Wednesday 1/20/21 and Benadryl 25mg every 6 hours round the clock for 5 days, Albuterol metered dose inhaler 2 puffs every 4-6 hours as needed in spacer (inhaler provided by ER) and Epic-pen to keep as needed for home in case of sudden onset reaction.  By Wednesday 1/20/21 symptoms almost completely resolved except for occasional irritated cough and itchy throat and feeling flushed and tired from the Benadryl and a little jittery from the steroids..
I was feeling very flush and couldn't get cooled down when all of a sudden I got very light headed, couldn't breath very good. Then the pounding in my chest started with pressure in my neck and head. After an hour I ended up in the ER with SVT. My heart was beating close to 200 beats a minute. My heart slowed down on its own to 114 beats a minute.
Pt received vaccine at approx. 3:30. At approx. 3:55 pt felt tingling of lips, tightness in chest, slight difficulty breathing and tongue swelling. Vitals obtained b/p 129/85 HR 91 O2 sat 100%. AT3:56 pt given epinephrine 0.3 mg IM to left thigh.  Pt started to feel some relief but feeling resumed after 10 minutes. 911 called at 4:04pm Arrived at 4:09 .  Taken to hospital by ambulance for further observation. AT disch100% heart rate 80arge b/p 127/66, O2
I received shot in left arm.  I began getting sore in injection area which I expected.  At around 630 in the evening, I began to feel a sharp pain going down my left arm from middle of shoulder to the hand.  This especially happened when I raised my arm.  I kept my left arm down to side trying to slowly move it during the day.  I contact Hot line for Hospital and explained issues.  They described certain reasons but said that I could take Motrin.  I began taking Motrin every 4 hours.  The next day I was able to raise arm about half way. The pain became a dull and aching from shoulder to hand. I continue to take Motrin.
pt recv vax & became very sleepy, sleeping through feedings & running a temp of 101 & higher axially;sx started about 24hr p/vax & lasted about a day & a half;
Fever - had glassy stare and lip quiver? Possible seizure x couple minutes.
This spontaneous report an office manager refers to a pediatric patient of unknown age and gender who was vaccinated with the first dose of VAQTA on 09-FEB-2012. The office manager mentioned that the patient was vaccinated with second dose of VAQTA early on 01-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. Physician came to the phone and provided the patient's name, authorization to contact him for more information and that this was a pediatric patient. The patient was not experiencing any known symptoms. No treatment information was reported. Additional information has been requested.
Localized swelling, deep red center about 2" across at injection site surrounded by a less swollen, less red area about 4" in diameter.  Extreme heat, itching, and sensitivity at injection area.  Continuous pain.  Low fever and low energy.  After four days contacted pharmacist who recommended OTC allergy pills and ibuprofen.  Took for three weeks.  Low fever went away in several days.  Stopped when the other symptoms had subsided.  One month after inoculation there is discoloration of the skin the same size as the 4" original discoloration.  No other symptoms.
This spontaneous report as received from a pharmacist refers to a 24 year old patient of unknown gender. It was reported that patient inadvertently received ZOSTAVAX dose and route not reported (lot # J005849; expiration date: 17-AUG-2014) in February 2014. The patient was supposed to received VARIVAX (Merck), but ZOSTAVAX was administered in error. The patient then received a first dose of VARIVAX (Merck) (dose, route and lot# were not reported) on 09-JUN-2014 and a second dose of VARIVAX (Merck) (dose, route and lot# were not reported) on 18-JUL-2014. Pharmacist stated that no adverse effects were reported. Additional information has been requested.
Patient awoke morning after vaccine to very sensitive/sore arm. Realized had redness and swelling extending from injection site down to elbow. Being prescribed ranitidine, prednisone, and BENADRYL to treat.
SERIOUS REACTION; This spontaneous report received from a consumer (husband of the patient) via social media (Twitter) via a company representative concerned a female of an unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, 1 total, start therapy date, were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient had a serious reaction (unspecified). On an unspecified date, the patient was hospitalized for 75 days and counting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of serious reaction was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210638913-COVID-19 VACCINE AD26.COV2.S-Serious Reaction. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Within 24 hours felt fatigued and arm soreness, mild body aches. Within one week felt joint pains which are ongoing (wrist, knees). Fatigue continues to -date and is not improving. Taking daily naps and not feeling rested.  Feel in a fog and constantly tired. Occasional headaches. Congestion for the last 3 weeks and mild dry cough. No fever. Hot flashes worsened.  Night sweats have worsened.  Fatigued and lethargic continues
Shingles (herpes zoster) infection; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 07Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included GERD (gastroesophageal reflux disease) and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paroxetine hydrochloride (PAXIL) and lansoprazole (MANUFACTURER UNKNOWN) both taken for unspecified indications from unknown dates and unknown if ongoing. The patient previously received cefaclor (CECLOR) (antibiotic) and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 18Apr2021 at 08:00 the patient experienced shingles (herpes zoster) infection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event which included treatment with valaciclovir (MANUFACTURE UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles (herpes zoster) infection was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
(R) facial pain requiring hospitalization. Onset 2d after vaccine. Headaches. Pain management, Gabapentin Rx.
12 hours after receiving my 3rd vaccine I became violently ill.; I vomited continuously for an hour; Chills; Shaking; Body aches; Chest pain; I now have brain fog; I now have brain fog and am unable to concentrate at work; I had to take 11/1 off of work because I have been extremely sick; Booster; This is a spontaneous report from a contactable healthcare professional, the patient. A 46-year-old non-pregnant female patient received a third (booster) dose of BNT162b2 (MANUFACTURER UNKNOWN; Lot Number: UNKNOWN) via an unspecified route of administration on 29Oct2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included sertraline hydrochloride (ZOLOFT) and ibuprofen (MANUFACTURER UNKNOWN); both from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took two doses of COVID-19 Vaccine of unknown manufacturer for COVID-19 immunisation, so primary Immunization series was complete. It was reported that the patient had experienced the side effects with dose one and two also on unknown dates. On 30Oct2021 at 01:30, the patient became violently ill (also reported 12 hours after receiving third vaccine), vomited continuously for an hour, she had chills, shaking, body aches, chest pain. At the time of report, the patient was having brain fog, was unable to concentrate at work and had to take off of work on 01Nov2021, because she had been extremely sick. The side effects the patient experienced were tenfold than what she had experienced with her dose first and second vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events became violently ill, vomited continuously for an hour, chills, shaking, body aches, chest pain was resolving, while that of brain fog, unable to concentrate at work and had to take off on 01Nov2021 because she had been extremely sick was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Back pain; Pain in his groin area; Pain in stomach muscles area; Butt aches; Pain in his thighs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (Back pain), GROIN PAIN (Pain in his groin area), ABDOMINAL PAIN UPPER (Pain in stomach muscles area), MUSCULOSKELETAL PAIN (Butt aches) and PAIN IN EXTREMITY (Pain in his thighs) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced BACK PAIN (Back pain), GROIN PAIN (Pain in his groin area), ABDOMINAL PAIN UPPER (Pain in stomach muscles area), MUSCULOSKELETAL PAIN (Butt aches) and PAIN IN EXTREMITY (Pain in his thighs). At the time of the report, BACK PAIN (Back pain), GROIN PAIN (Pain in his groin area), ABDOMINAL PAIN UPPER (Pain in stomach muscles area), MUSCULOSKELETAL PAIN (Butt aches) and PAIN IN EXTREMITY (Pain in his thighs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that he visited a health care provider on 15-Mar-2021 and also on 5-Apr-2021 and has yet to receive any sort of treatment for events.
Information has been received on 06-JUN-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2015, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated at a hospital for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Soreness of the (L) deltoid without swelling/redness or ecchymosis. Tenderness of the injection site only. Pt requested report be made.
08/28/22 presents to EC ED for "right chest pain". PMHx of "right lung transplant on chronic immunosuppression, GERD, hypothyroidism, prior bladder cancer, osteoporosis, CKD, MDD/GAD"
The patient complained of dizziness, pain in the left arm, thick tongue, and feeling faint within an hour post vaccination.
This spontaneous report as received from other, as part of a marketing research program, refers to a 70 year old male patient with hypertension and high cholesterol. On an unknown date the patient was vaccinated with ZOSTAVAX (administered once, route, lot number and expiration date not reported). The patient on high blood pressure and cholesterol medicine as concomitant therapies. On an unknown date 1 day after receiving ZOSTAVAX the patient had fever and headache. The outcome of headache and fever was reported as recovered/resolved with sequelae on an unknown date. The reporter considered headache and fever to be related to ZOSTAVAX. The reporter considered the events as not serious. Additional information is not expected.
I am getting like shingles and now I am getting like some other skin issues; then also like I get almost like all over shingles at 30; I am getting like shingles and now I am getting like some other skin issues; then also like I get almost like all over shingles at 30; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8736), via an unspecified route of administration in upper left arm on 19May2021 (at the age of 31 years old) as single for covid-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8731), via an unspecified route of administration in upper left arm on 28Apr2021 (at the age of 31 years old) for covid-19 immunisation. The patient medical history was not reported. Family medical history related to adverse event: Reporter stated that not that he know of and they just took the vaccine and never had any of that. Concomitant medications included gabapentin; lisdexamfetamine mesilate (VYVANSE) for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Reporter stated that on 28May2021, after application he had little side effect for like all over a month now, he is not sure why they and know they gave him since second dose from the vaccine and he getting like shingles and now getting like some other skin issues and then also like he get almost like all over shingles at 30. He never had shingles before never really had or anything else like elementary school almost 32 now, like last when he had a hearty look like a long time. For treatment consumer stated for like shingles and stuff, they haven't really gave him anything for it. He knew they keep try to give him antibiotic so that it can do any good. No treatment was received for the event. The outcome of events was unknown.
This infant vomited 3 xs  in the middle of the night, when she awoke, she had a fever.
On 4/23/2021 (day after vaccine left arm became very sore, I was extremely tired-exhausted, began about 8:30AM. Later that evening  around 7:00 PM, my heart started to beat faster then suddenly slowed down and then skipped a beat, but this didn't last a couple  minutes. 10 pm noticed my left upper arm was swelling in a large area.  It was swollen and was very painful.    4/24/21 My upper left arm was very swollen and had purple colored spots around the swollen area.  I also noticed that my lymph glands under my left arm were swollen.  The swelling on upper arm started to go down on 4/25/21, but lymph gland under left arm was still swollen for several days.
Nearly immediate onset of throat tightness, facial swelling, difficulty breathing. Became unable to talk. Epinephrine, benedryl and zofran were immediately administered by on-site paramedics. Was able to talk after administration of Epi. Was transported to hospital via ambulance. We later heard that he had another episode within the hour and was admitted for observation.
After receiving 2nd dose of the Pfizer Vaccine at 4:00 PM, patient was seated in the waiting area. At  exactly 4:05 PM, Patients boyfriend motioned to staff to respond to said patient and asked for water. When staff observed patient, on site RN was motioned over as well. There-in, patient was observed to be pale and sweaty, and she was seated but leaning against boyfriend for support. Upon being asked name,  patient stuttered trying to state first name and could only produce ("T" sound with lips) Patient could not speak full word. By this time, blood pressure cuff and Pulse-ox were brought to assess vitals. Blood pressure - 55/35 and Pulse was 49. Respiration was 20 breaths per minute and shallow. Upon observing blood pressure, ambulance was called. Ambulance responded within 5 minutes. During time waiting for ambulance, patient had improvement and was able to state name and location. Patient was given water, could not hold but with assistance from boyfriend, was able to drink through a straw. Upon ambulance arrival, care was transferred and was transported to local hospital.
Beginning about 3;00 pm the day of the injection (8:16 am), soreness at injection site,. Beginning about 5:00 pm, severe headache, chills, fever (101.5), teeth hurt, arm was very tender, lethargy. The next day, the headache, chills (but less intense), and extreme lethargy continued. Symptoms started to subside late in the day. By the next morning, only mild headache remained and subsided as the day went on. Arm soreness continued throughout the day into the evening.
Dizziness; Muscle weakness in arms and legs; speech difficulty; headache; mental fog and confusion; mental fog and confusion; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in the left arm on 26Feb2021 17:00 as a single dose for COVID-19 immunisation. Medical history included COVID from an unknown date prior vaccination. The patient had no known allergies. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient experienced dizziness muscle weakness in arms and legs, speech difficulty, headache, mental fog and confusion on 01Mar2021 09:45AM. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, and hospitalization for four (4) days. Treatment included, MRI, CT scan, and "migraine cocktail" on unspecified date. Outcome of the events was not recovered. The patient had a nasal swab Covid test post vaccination on 01Mar2021 with Negative result.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax for prophylaxis;1 hr later, exp a pink & reticular rash
" Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Before the 3rd shot they gave me a steroid and Benadryl and the hives weren't as bad, but they lasted for about 2 weeks.
COVID-19 contracted at airport; COVID-19 contracted at airport; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown), all intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Paxlovid for Covid-19 Treatment, reaction(s): "COVID-19/ Negative Reaction on Paxlovid", notes: Paxlovid (Nirmatrelvir; Ritonavir), Route of administration: Unknown. Therapy Dates/Duration: 2022-2022.; Paxlovid for Covid-19 Treatment, reaction(s): "Influenza", notes: Paxlovid (Nirmatrelvir; Ritonavir), Route of administration: Unknown. Therapy Dates/Duration: 2022-2022.; Paxlovid for Covid-19 Treatment, reaction(s): "Feeling bad", notes: Paxlovid (Nirmatrelvir; Ritonavir), Route of administration: Unknown. Therapy Dates/Duration: 2022-2022; Humira for Psoriatic Arthritis, reaction(s): "Influenza", notes: Drug: Humira (Solution for injection in pre-filled pen) (Adalimumab), 1160837. Daily Dose: 1) Citrate free (40 mg, 1 in 2 wk), Route of admin: Subcutaneous. Therapy Dates/Duration: Unk-2022; Humira for Psoriatic Arthritis, reaction(s): "Feeling bad", notes: Drug: Humira (Solution for injection in pre-filled pen) (Adalimumab), 1160837. Daily Dose: 1) Citrate free (40 mg, 1 in 2 wk), Route of admin: Subcutaneous. Therapy Dates/Duration: Unk-2022. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 30Jun2022, outcome "unknown", COVID-19 (medically significant) with onset 30Jun2022, outcome "recovered" (2022) and all described as "COVID-19 contracted at airport". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Jun2022) Positive. Clinical Course: This is a solicited report by a consumer of a 36-year-old female with events of non-serious influenza, COVID-19 contracted at airport, feeling badly and negative reaction on Paxlovid with Humira (Adalimumab). There was no reported medical history. In 2022, the patient experienced negative reaction on Paxlovid. On 29May2022, the patient experienced Influenza. In Jun2022, the patient experienced COVID-19 contracted at airport and feeling badly. On 05Jun2022, the influenza resolved. In 2022, the COVID-19 contracted at airport resolved. Paxlovid (Nirmatrelvir; Ritonavir) was also considered suspect. It was unknown if patient was enrolled in a Covid-19 Vaccine Trial.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.